Education
About Us
Working with TipRanks
Follow Us
Merit Medical (MMSI)
:MMSI
MMSI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$70.70 - $111.45
Previous CloseN/A
Volume49.13K
Average Volume (3M)592.07K
Market Cap
$5.99B
Enterprise Value$6.18B
Total Cash (Recent Filing)$581.92M
Total Debt (Recent Filing)$872.75M
Price to Earnings (P/E)51.7
Beta0.49
Next Earnings
Apr 24, 2025EPS Estimate
0.75Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.03
Shares Outstanding58,834,568
10 Day Avg. Volume861,271
30 Day Avg. Volume592,066
Financial Highlights & Ratios
PEG Ratio1.97
Price to Book (P/B)N/A
Price to Sales (P/S)4.42
Price to Cash Flow (P/CF)21.80
P/FCF Ratio23.20
Enterprise Value/Market Cap1.03
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit9.60
Enterprise Value/Ebitda20.76
Forecast
1Y Price Target
$117.67Price Target Upside12.23% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
---
Merit Medical Systems News
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMMSI's Q4 revenue of $355.2 million easily exceeded the expectation of $344.8 million, showcasing strong financial performance.
Operational EfficiencyThe company showed strong operating leverage with a 53.4% adjusted gross margin, contributing to increasing operational efficiency.
Bears Say
Earnings Guidance2025 EPS guidance was lower than the Street because of two primary headwinds, impacting investor expectations negatively.
---
Ownership Overview
2.42% Insiders
38.86% Mutual Funds
27.56% Other Institutional Investors
4.84% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MMSI FAQ
What was Merit Medical’s price range in the past 12 months?
Merit Medical lowest stock price was $70.70 and its highest was $111.45 in the past 12 months.
What is Merit Medical’s market cap?
Merit Medical’s market cap is $5.99B.
When is Merit Medical’s upcoming earnings report date?
Merit Medical’s upcoming earnings report date is Apr 24, 2025 which is in 48 days.
How were Merit Medical’s earnings last quarter?
Merit Medical released its earnings results on Feb 25, 2025. The company reported $0.93 earnings per share for the quarter, beating the consensus estimate of $0.829 by $0.101.
Is Merit Medical overvalued?
According to Wall Street analysts Merit Medical’s price is currently Undervalued.
Does Merit Medical pay dividends?
Merit Medical does not currently pay dividends.
What is Merit Medical’s EPS estimate?
Merit Medical’s EPS estimate is 0.75.
How many shares outstanding does Merit Medical have?
Merit Medical has 58,834,568 shares outstanding.
What happened to Merit Medical’s price movement after its last earnings report?
Merit Medical reported an EPS of $0.93 in its last earnings report, beating expectations of $0.829. Following the earnings report the stock price went down -1.549%.
Which hedge fund is a major shareholder of Merit Medical?
Currently, no hedge funds are holding shares in MMSI
---
Merit Medical Systems Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$117.67 (12.23% Upside)
$117.67 (12.23% Upside)
Blogger Sentiment
Bullish
MMSI Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 226.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $6.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.5%
Last 30 Days ▲ 17.3%
Last 30 Days ▲ 17.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
39.59%
12-Months-Change
Fundamentals
Return on Equity
9.32%
Trailing 12-Months
Asset Growth
4.01%
Trailing 12-Months
Company Description
Merit Medical
Merit Medical Systems, Inc. engages in the manufacture and market of proprietary disposable medical devices. It operates through Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates advanced non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger and William Padilla in July 1987 and is headquartered in South Jordan, UT.
---
MMSI Company Deck
---
MMSI Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with significant revenue growth and profitability increases, successful acquisitions, and strong free cash flow. However, challenges in international sales, particularly in the EMEA and China regions, as well as increased operating expenses and tariff uncertainties, were noted.Read More>---
MMSI Stock 12 Month Forecast
Average Price Target
$117.67
▲(12.23% Upside)
Technical Analysis
Abbott Laboratories
―
Boston Scientific
―
Hologic
―
Medtronic
―
Zimmer Biomet Holdings
―
Best Analysts Covering MMSI
1 Year
1 Year Success Rate
19/21 ratings generated profit
1 Year Average Return
+17.22%
reiterated a buy rating 9 days ago
Copying Jason Bednar's trades and holding each position for 1 Year would result in 90.48% of your transactions generating a profit, with an average return of +17.22% per trade.
---